ONLINE DATABASE SEARCH - OI-LS-289-MEMO
1. 42815 OI-LS-289; PUBMED-OI-2/11/2004
Hepatitis C. Development of new drugs and clinical trials: Promises and pitfalls. Summary of an AASLD hepatitis single topic conference, Chicago, IL, February 27-March 1, 2003
Pawlotsky, JM and McHutchison, JG
Hepatology 2004. 39(2): 554-567
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14768012&dopt=abstract
2. 42816 OI-LS-289; PUBMED-OI-2/11/2004
Macro-array and bioinformatic analyses reveal mycobacterial 'core' genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex
Marmiesse, M, Brodin, P, Buchrieser, C, Gutierrez, C, Simoes, N, Vincent, V, Glaser, P, Cole, ST, and Brosch, R
Microbiology 2004. 150(Pt 2): 483-496
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14766927&dopt=abstract
3. 42817 OI-LS-289; PUBMED-OI-2/11/2004
Genotypic and Phenotypic Characterization of Drug-Resistant Mycobacterium tuberculosis Isolates from Rural Districts of the Western Cape Province of South Africa
Streicher, EM, Warren, RM, Kewley, C, Simpson, J, Rastogi, N, Sola, C, Van Der Spuy, GD, Van HelDen PD, and Victor, TC
J Clin Microbiol 2004. 42(2): 891-894
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14766882&dopt=abstract
4. 42818 OI-LS-289; SCIFINDER-OI-2/4/2004
A complete shikimate pathway in Toxoplasma gondii: an ancient eukaryotic innovation
Campbell, SA, Richards, TA, Mui, EJ, Samuel, BU, Coggins, JR, McLeod, R, and Roberts, CW
International Journal for Parasitology 2004. 34(1): 5-13
5. 42819 OI-LS-289; SCIFINDER-OI-2/4/2004
CryptoDB: the Cryptosporidium genome resource
Puiu, Daniela, Enomoto, Shinichiro, Buck, Gregory A, Abrahamsen, Mitchell S, and Kissinger, Jessica C
Nucleic Acids Research 2004. 32(Database): D329-D331
6. 42820 OI-LS-289; PUBMED-OI-2/11/2004
Detection of rifampin-resistant Mycobacterium tuberculosis strains by using a specialized oligonucleotide microarray
Yue, J, Shi, W, Xie, J, Li, Y, Zeng, E, Liang, L, and Wang, H
Diagn Microbiol Infect Dis 2004. 48(1): 47-54
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14761721&dopt=abstract
7. 42821 OI-LS-289; PUBMED-OI-2/11/2004
Virtual generation of agents against Mycobacterium tuberculosis. A QSAR study
Besalu, E, Ponec, R, and de Julian-Ortiz, JV
Mol Divers 2003. 6(2): 107-20
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14761161&dopt=abstract
8. 42822 OI-LS-289; PUBMED-OI-2/11/2004
Design, Synthesis, and Evaluation of 9-d-Ribitylamino-1,3,7,9-tetrahydro-2,6,8-purinetriones Bearing Alkyl Phosphate and alpha,alpha-Difluorophosphonate Substituents as Inhibitors of Riboflavin Synthase and Lumazine Synthase
Cushman, M, Sambaiah, T, Jin, G, Illarionov, B, Fischer, M, and Bacher, A
J Org Chem 2004. 69(3): 601-612
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14750781&dopt=abstract
9. 42823 OI-LS-289; PUBMED-OI-2/11/2004
History of the development of azole derivatives
Maertens, JA
Clin Microbiol Infect 2004. 10 Suppl 1: 1-10
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14748798&dopt=abstract
10. 42824 OI-LS-289; SCIFINDER-OI-2/4/2004
Synthesis and antimicrobial activity of some benzazole derivatives
Karali, N, Cesur, N, Guersoy, A, Ates, Oe, OezDen S, Oetuek, G, and Birteksoez, S
Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry 2004. 43B(1): 212-216
11. 42825 OI-LS-289; PUBMED-OI-2/11/2004
Citrafungins A and B, Two New Fungal Metabolite Inhibitors of GGTase I with Antifungal Activity
Singh, SB, Zink, DL, Doss, GA, Polishook, JD, Ruby, C, Register, E, Kelly, TM, Bonfiglio, C, Williamson, JM, and Kelly, R
Org Lett 2004. 6 (3): 337-40
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14748587&dopt=abstract
12. 42826 OI-LS-289; PUBMED-OI-2/11/2004
Development of a GB virus B marmoset model and its validation with a novel series of hepatitis C virus NS3 protease inhibitors
Bright, H, Carroll, AR, Watts, PA, and Fenton, RJ
J Virol 2004. 78(4): 2062-71
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14747571&dopt=abstract
13. 42827 OI-LS-289; PUBMED-OI-2/11/2004
A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction
Khan, S, Zimmermann, A, Basler, M, Groettrup, M, and Hengel, H
J Virol 2004. 78(4): 1831-42
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14747547&dopt=abstract
14. 42828 OI-LS-289; PUBMED-OI-2/11/2004
P-glycoprotein inhibitors modulate accumulation and efflux of xenobiotics in extra and intracellular Toxoplasma gondii
Sauvage, V, Aubert, D, Bonhomme, A, Pinon, JM, and Millot, JM
Mol Biochem Parasitol 2004. 134(1): 89-95
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14747146&dopt=abstract
15. 42829 OI-LS-289; PUBMED-OI-2/11/2004
Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study
Kontos, F, Maniati, M, Costopoulos, C, Gitti, Z, Nicolaou, S, Petinaki, E, Anagnostou, S, Tselentis, I, and Maniatis, AN
J Microbiol Methods 2004. 56(2): 291-4
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14744458&dopt=abstract
16. 42830 OI-LS-289; PUBMED-OI-2/11/2004
Tuberculosis: not a thing of the past
Murphy, D
Posit Aware 2003. 14(6): 35
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14743793&dopt=abstract
17. 42831 OI-LS-289; PUBMED-OI-2/11/2004
Inhibition of the subgenomic hepatitis C virus replicon in huh-7 cells by 2'-deoxy-2'-fluorocytidine
Stuyver, LJ, McBrayer, TR, Whitaker, T, Tharnish, PM, Ramesh, M, Lostia, S, Cartee, L, Shi, J, Hobbs, A, Schinazi, RF, Watanabe, KA, and Otto, MJ
Antimicrob Agents Chemother 2004. 48(2): 651-4
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14742230&dopt=abstract
18. 42832 OI-LS-289; PUBMED-OI-2/11/2004
Effect of interferon alpha and cell cycle progression on translation mediated by the hepatitis C virus 5' untranslated region: a study using a transgenic mouse model
TakeDa Y, Okoshi, S, Suzuki, K, Yano, M, Gangemi, JD, Jay, G, Asakura, H, and Aoyagi, Y
J Viral Hepat 2004. 11(1): 33-44
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14738556&dopt=abstract
19. 42833 OI-LS-289; PUBMED-OI-2/11/2004
A new indolizinone from Polygonatum kingianum
Wang, YF, Lu, CH, Lai, GF, Cao, JX, and Luo, SD
Planta Med 2003. 69(11): 1066-8
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14735451&dopt=abstract
20. 42834 OI-LS-289; SCIFINDER-OI-2/4/2004
Recombinant Mycobacteria expressing major extracellular non-fusion proteins of Mycobacteria or other intracellular pathogen for inducing immune responses((USA))
Horwitz, Marcus A, Harth, Gunter, and Tullius, Michael V
PATENT: US 20040009184 A1; ISSUE DATE: 20040115
APPLICATION: 2003-46395; PP: 34 pp., Cont.-in-part of U.S. Pat. Appl. 2003 124,135.
21. 42835 OI-LS-289; PUBMED-OI-2/11/2004
Hepatitis C virus replicons finally get to second base
Evans, MJ and Rice, CM
Gastroenterology 2003. 125(6): 1892-5
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14724844&dopt=abstract
22. 42836 OI-LS-289; PUBMED-OI-2/11/2004
A reporter-based assay for identifying hepatitis C virus inhibitors based on subgenomic replicon cells
Lee, JC, Chang, CF, Chi, YH, Hwang, DR, and Hsu, JT
J Virol Methods 2004. 116(1): 27-33
HYPERLINK: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14715304&dopt=abstract
23. 42837 OI-LS-289; WOS-HIV-2/1/2004
Synthesis and evaluation of antimicrobial activity of new 3-hydroxy-6-methyl-4-oxo-4H-pyran-2-carboxamide derivatives
Aytemir, MD, Erol, DD, Hider, RC, and Ozalp, M
TURK J CHEM 2003. 27(6): 757-764
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187955700012
24. 42838 OI-LS-289; SCIFINDER-OI-2/4/2004
Individual Mycobacterium tuberculosis resuscitation-promoting factor homologues are dispensable for growth in vitro and in vivo
Tufariello, JoAnn M, Jacobs, William R Jr, and Chan, John
Infection and Immunity 2004. 72(1): 515-526
25. 42839 OI-LS-289; WOS-HIV-2/1/2004
Novel 3 '-deoxy analogs of the anti-HBV agent entecavir: synthesis of enantiomers from a single chiral epoxide
Ruediger, E, Martel, A, Meanwell, N, Solomon, C, and Turmel, B
TETRAHEDRON LETT 2004. 45(4): 739-742
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187897900019
26. 42840 OI-LS-289; SCIFINDER-OI-2/4/2004
The Prodrug Activator EtaA from Mycobacterium tuberculosis Is a Baeyer-Villiger Monooxygenase
Fraaije, Marco W, Kamerbeek, Nanne M, Heidekamp, Annelies J, Fortin, Riccardo, and Janssen, Dick B
Journal of Biological Chemistry 2004. 279(5): 3354-3360
27. 42841 OI-LS-289; WOS-HIV-2/1/2004
ANTIMIC: a database of antimicrobial sequences
Brahmachary, M, Krishnan, SPT, Koh, JLY, Khan, AM, Seah, SH, Tan, TW, Brusic, V, and Bajic, VB
NUCLEIC ACIDS RES 2004. 32: D586-D589
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188079000139
28. 42842 OI-LS-289; SCIFINDER-OI-2/4/2004
Biflavonoids, flavonoids, chalcones and chalcone-like compounds and use against mycobacterium infections ((Advanced Life Sciences, Inc. USA)
Lin, Yuh-meei
PATENT: US 6677350 B1; ISSUE DATE: 20040113
APPLICATION: 2000-11771; PP: 19 pp., Cont.-in-part of U.S. Provisional Ser. No. 155,519.
29. 42843 OI-LS-289; SCIFINDER-OI-2/4/2004
Mycobacterium tuberculosis Ribose-5-phosphate Isomerase has a Known Fold, but a Novel Active Site
Roos, Annette K, Andersson, CEvalena, Bergfors, Terese, Jacobsson, Micael, Karlen, Anders, Unge, Torsten, Jones, TAlwyn, and Mowbray, Sherry L
Journal of Molecular Biology 2004. 335(3): 799-809
30. 42844 OI-LS-289; SCIFINDER-OI-2/4/2004
M. tuberculosis entry and growth using macrophage models
Toossi, Zahra and Schlesinger, Larry S
CONFERENCE: Tuberculosis 2004: 1-24
31. 42845 OI-LS-289; SCIFINDER-OI-2/4/2004
Preparation of rifabutine derivatives useful as antimicrobial agents((Instituto Nacional de Engenharia e Tecnologia Industrial, Port.)
Medeiros, Maria, Costa, Maria, Figueiredo, Ricardo, Rosa, Maria, Curto, Maria, Santos, Lina, Cruz, Maria, Gaspar, Maria, and Feio, Sonia
PATENT: WO 2004005298 A1; ISSUE DATE: 20040115
APPLICATION: 2003; PP: 44 pp.
32. 42846 OI-LS-289; SCIFINDER-OI-2/4/2004
Alkaloid derivatives as inhibitors of acylglucosaminylinositol amidase and antibacterial agents ((The United States of America, as Represented by the Secretary Department of Health and Human Services USA)
Bewley, Carole, Nicholas, Gillian, Nicolaou, KC, Barluenga, Sofia, Pfefferkorn, Jeffrey, and Hughes, Robert
PATENT: WO 2004004659 A2; ISSUE DATE: 20040115
APPLICATION: 2003; PP: 61 pp.
33. 42847 OI-LS-289; WOS-HIV-2/1/2004
Cyclic voltammetric determination of free radical species from nitroimidazopyran: a new antituberculosis agent
Bollo, S, Nunez-Vergara, LJ, and Squella, JA
J ELECTROANAL CHEM 2004. 562(1): 9-14
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188066500002
34. 42848 OI-LS-289; SCIFINDER-OI-2/4/2004
Reagents and method for diagnosis of active tuberculosis or active acid-fast bacterial diseases, and test tools and kits using the reagents((Japan BCG Laboratory, Japan and Nippon Koketsu Kanso Kenkyusho K. K.) )
Yano, Ikuya, Sato, Yukihiro, Otsuka, Katsuji, Fujita, Yukiko, and Doi, Takeshi
PATENT: JP 2004003912 A2; ISSUE DATE: 20040108
APPLICATION: 2002-47148; PP: 20 pp.
35. 42849 OI-LS-289; SCIFINDER-OI-2/4/2004
Preparation of acyclic nucleosides and nucleotides as antiviral agents((Taiwan))
Hakimelahi, Gholam Hossein
PATENT: US 2004002475 A1; ISSUE DATE: 20040101
APPLICATION: 2002-52806; PP: 21 pp.
36. 42850 OI-LS-289; WOS-HIV-2/1/2004
Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives
Beaulieu, PL, Bos, M, Bousquet, Y, Fazal, G, Gauthier, J, Gillard, J, Goulet, S, LaPlante, S, Poupart, MA, Lefebvre, S, McKercher, G, Pellerin, C, Austel, V, and Kukolj, G
BIOORG MED CHEM LETT 2004. 14(1): 119-124
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187862000023
37. 42851 OI-LS-289; WOS-HIV-2/1/2004
Discovery of a novel bicycloproline P2 bearing peptidyl alpha-ketoamide LY514962 as HCV protease inhibitor
Yip, Y, Victor, F, Lamar, J, Johnson, R, Wang, QM, Barket, D, Glass, J, Jin, L, Liu, LF, Venable, D, Wakulchik, M, Xie, CP, Heinz, B, Villarreal, E, Colacino, J, Yumibe, N, Tebbe, M, Munroe, J, and Chen, SH
BIOORG MED CHEM LETT 2004. 14(1): 251-256
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187862000049
38. 42852 OI-LS-289; WOS-HIV-2/1/2004
P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl alpha-ketoamide based HCV protease inhibitors
Victor, F, Lamar, J, Snyder, N, Yip, Y, Guo, DQ, Yumibe, N, Johnson, RB, Wang, QM, Glass, JI, and Chen, SH
BIOORG MED CHEM LETT 2004. 14(1): 257-261
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000187862000050
39. 42853 OI-LS-289; SCIFINDER-OI-2/4/2004
Preparation of imidazopyridines as viral inhibitors((K.U.Leuven Research & Development, Belg. and Gilead Sciences, Inc.)
Neyts, Johan, Puerstinger, Gerhard, and De Clercq, Erik
PATENT: WO 2004005286 A2; ISSUE DATE: 20040115
APPLICATION: 2003; PP: 149 pp.
40. 42854 OI-LS-289; SCIFINDER-OI-2/4/2004
Preparation of 1,2-disubstituted 1,4-dihydro-4-oxoquinoline compounds as antiviral agents ((Maruishi Pharmaceutical Co., Ltd. Japan )
Tamura, Takashi, Kuriyama, Haruo, Agoh, Masanobu, Agoh, Yumi, Soga, Manabu, and Mori, Teruyo
PATENT: EP 1380575 A1; ISSUE DATE: 20040114
APPLICATION: 2000; PP: 44 pp.
41. 42855 OI-LS-289; WOS-HIV-2/8/2004
In vitro evaluation of the antimicrobial activity of chlorhexidine and sodium hypochlorite
Vianna, ME, Gomes, BPFA, Berber, VB, Zaia, AA, Ferraz, CCR, and De Souza, FJ
ORAL SURG ORAL MED O 2004. 97(1): 79-84
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188115800016
42. 42856 OI-LS-289; SCIFINDER-OI-2/4/2004
Preparation of nucleoside derivatives as antiviral agents and inhibitors of RNA-dependent RNA viral polymerase ((Merck & Co., Inc. USA and Isis Pharmaceuticals, Inc.)
Bhat, Balkrishen, Carroll, Steven S, Eldrup, Anne B, Maccoss, Malcolm, Olsen, David B, and Prakash, Thazha P
PATENT: WO 2004007512 A2; ISSUE DATE: 20040122
APPLICATION: 2003; PP: 50 pp.
43. 42857 OI-LS-289; SCIFINDER-OI-2/4/2004
Use of hepatitis C virus p7 protein for screening for antiviral drugs ( (University of Leeds, UK)
Rowlands, David and Griffin, Stephen
PATENT: WO 2004005333 A1; ISSUE DATE: 20040115
APPLICATION: 2003; PP: 33 pp.
44. 42858 OI-LS-289; WOS-HIV-2/8/2004
Reverse transcriptase activity of hepatitis B virus (HBV) DNA polymerase within core capsid: Interaction with deoxynucleoside triphosphates and anti-HBV L-deoxynucleoside analog triphosphates
Lam, W, Li, Y, Liou, JY, Dutschman, GE, and Cheng, YC
MOL PHARMACOL 2004. 65(2): 400-406
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188329800016
45. 42859 OI-LS-289; SCIFINDER-OI-2/4/2004
E2 glycoprotein-based methods for identification of inhibitors of hepatitis C virus (HCV) infection, therapeutic methods, and methods for LDL level reduction((University of Iowa Research Foundation, USA)
Stapleton, Jack T and Wuenschmann, Sabina
PATENT: WO 2004003141 A2; ISSUE DATE: 20040108
APPLICATION: 2003; PP: 135 pp.
46. 42860 OI-LS-289; SCIFINDER-OI-2/4/2004
Preparation of N-alkenyl carboxamide inhibitors of HCV NS5b polymerase for treating hepatitis C viral infections and associated diseases((Pharmacia & Upjohn Company, USA and Finzel, Barry C.)
Gao, Hua, Greene, Meredith L, Gross, Rebecca J, Nugent, Richard A, and Pfefferkorn, Jeffrey
PATENT: WO 2004002977 A1; ISSUE DATE: 20040108
APPLICATION: 2003; PP: 186 pp.
47. 42861 OI-LS-289; SCIFINDER-OI-2/4/2004
(E)-1-[[(2E, 4E)-1-hexyl-2,4-octadecadienyl]oxy]-2-hydroxydiazine and a pharmaceutical composition for treating hepatitis ((Biokorea Co., Ltd. S. Korea)
Lea, Young-Sung, Ahn, Dong-Ho, Lim, Yoong-Ho, Yoon, Seung-Kew, Kim, Man-Bae, Kim, Nam-Jin, Chang, Eun-Joo, and Lee, Min-Kyung
PATENT: WO 2004002945 A1; ISSUE DATE: 20040108
APPLICATION: 2003; PP: 41 pp.
48. 42862 OI-LS-289; SCIFINDER-OI-2/4/2004
Preparation of N-(phenylaminophenyl)carboxamide and related compound inhibitors of HCV NS5b polymerase for treating hepatitis C viral infections and associated diseases((Pharmacia & Upjohn Company, USA)
Finzel, Barry C, Funk, Lee A, Kelly, Robert C, Reding, Matthew T, and Wicnienski, Nancy Anne
PATENT: WO 2004002944 A1; ISSUE DATE: 20040108
APPLICATION: 2003; PP: 45 pp.
49. 42863 OI-LS-289; SCIFINDER-OI-2/4/2004
Preparation of N,N'-bis(o-carboxyphenyl)-o-diaminobenzene derivative inhibitors of HCV NS5b polymerase for treating hepatitis C viral infections and associated diseases((Pharmacia & Upjohn Company, USA and Pharmacia Italia S.p.A.))
Battistini, Carlo, Casuscelli, Francesco, Kelly, Robert C, Maggiora, Linda L, Mitchell, Mark A, Piutti, Claudia, and Reding, Matthew T
PATENT: WO 2004002940 A1; ISSUE DATE: 20040108
APPLICATION: 2003; PP: 74 pp.
50. 42864 OI-LS-289; SCIFINDER-OI-2/4/2004
2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections((Idenix (Cayman) Limited, Cayman I. and Universita Degli Studi di Cagliari))
Sommadossi, Jean-Pierre and La Colla, Paolo
PATENT: WO 2004002422 A2; ISSUE DATE: 20040108
APPLICATION: 2003; PP: 110 pp.
51. 42865 OI-LS-289; SCIFINDER-OI-2/4/2004
In vitro antiviral susceptibility of full-length clinical hepatitis B virus isolates cloned with a novel expression vector
Yang, Huiling, Westland, Christopher, Xiong, Shelly, and Delaney, William E
Antiviral Research 2004. 61(1): 27-36
52. 42866 OI-LS-289; WOS-HIV-2/8/2004
Synthesis of a novel class of sulfonium ions as potential inhibitors of UDP-galactopyranose mutase
Ghavami, A, Chen, JJW, and Pinto, BM
CARBOHYD RES 2004. 339(2): 401-407
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188118300025
53. 42867 OI-LS-289; WOS-HIV-2/8/2004
Acetylene-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme
Senior, SJ, Illarionov, PA, Gurcha, SS, Campbell, IB, Schaeffer, ML, Minnikin, DE, and Besra, GS
BIOORG MED CHEM LETT 2004. 14(2): 373-376
HYPERLINK: http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188119500016
54. 42868 OI-LS-289; WOS-HIV-2/8/2004
Hepatitis CNS3 protease inhibition by peptidyl-alpha-ketoamide inhibitors: kinetic mechanism and structure
Liu, YY, Stoll, VS, Richardson, PL, Saldivar, A, Klaus, JL, Molla, A, Kohlbrenner, W, and Kati, WM
ARCH BIOCHEM BIOPHYS 2004. 421(2): 207-216
HYPERLINK:
http://publishorperish.nih.gov/isicgi/gateway/Gateway.cgi?KeyUT=000188117600004